IRCT20201003048912N1招募中3 期
The effect of growth hormone on increasing pregnancy success rate in women with unexplained recurrent implantation failure: A multicenter clinical randomized study.
Avicenna Reseacrh Institute0 个研究点目标入组 356 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 356
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 22 years 至 39 years（—）
- 性别
- Female
入选标准
- •have a history of more than two previous unexplained IVF failures (3=)(despite transfer of minimum one good grade A blastocyst embryo) , no previous hormone growth cycle, no other interventions in this cycle(hystroscopy and Imunomodolator drugs ), no donation cycle, no hormone contraindications, not having hydrosalpinx, , having at least one good grade A blastocyst freezed embryo for transfer , FSH=10, AMH=1.8
排除标准
- •Age= 40 years, BMI=30, endometriosis, severe oligospermia, (Sperm count <5 ×106 /mL ,Normal morphology <2% in the sperm analysis test ) DFI =30% , patients with hydrosalpinx, kidney and liver diseases, diabetes,hypertention and thyroid( anti-Tpo>500) and autoimmune diseases and local allergic reactions and benign increase in intracranial pressure, submucosal myoma, metabolic syndrome, sex selection , karyotype disorder, uterian anomalis, Synechsia, Hx of thin enodmetrium(endometrial line<7mm) , no patient consent
研究者
相似试验
招募中
3 期
Effect of Growth Hormone on Improve Pregnancy Rate in Women with poor ovarian responseIRCT20201003048912N2Avicenna University Jihad Infertility Center Avicenna124
招募中
2 期
Effect of Gh on pregnancy outcome in RIFInfertility.Female infertility of other originN97.8IRCT20091012002576N34Tehran University of Medical Sciences60
已完成
不适用
Growth hormone deficiency and clottingISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
已完成
不适用
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
进行中（未招募）
不适用
Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III? - SMA-GHSpinal muscular atrophy (SMA) is an autosomal recessive disease. Due to the genetic defect, a molecule called spinal motor neuron” (SMN) protein is lacking, resulting in muscle weakness. In SMAs muscle weakness is found most often at the level of proximal muscles. The disease is life-threatening and chronically debilitating.EUCTR2005-002822-78-DEKlinik Neuropädiatrie und Muskelkrankheiten20